News & Analysis on Clinical Trial Services & Contract Research And Development
An AstraZeneca collaboration has identified the location of a schizophrenia gene that is set to offer hope for more effective drugs. The gene appears to affect the production of myelin, the material that insulates nerve fibres.
A target-seeking molecule that can be used to visualise and treat cancer tumours is set to improve detection and treatment of the killer disease, which is a lot more successful if therapy begins at an earlier stage.
British catalyst technologies firm Reaxa has slashed the prices of its encapsulated catalysts by two-thirds following increased demand for production scale quantities in pharma applications.
Scientists think that their latest discovery could result in the production of new drugs to treat Kaposi sarcoma tumour growth, which is the most frequent tumour in AIDS patients and is caused by infection of the patients with the Kaposi...
Polymer Laboratories have launched a new Evaporative Light Scattering Detector (ELSD) that it claims will improve the analysis of pharmaceutical compounds at low temperatures.